Added to YB: 2025-07-29
Pitch date: 2025-07-25
FBIO [bullish]
Fortress Biotech, Inc.
+31.63%
current return
Author Info
No bio for this author
Company Info
Fortress Biotech, Inc., a biopharmaceutical company, engages in the development and commercialization of biopharmaceutical products.
Market Cap
$58.3M
Pitch Price
$1.96
Price Target
25.00 (+933%)
Dividend
N/A
Sector
Biotechnology
Category
dividend
Fortress Biotech – Update regarding CAEL-101 announcement, EMROSI, CUTX-101 news & Dotinurad, Triplex potential strategic options in the future
FBIOP: Dividend reinstatement potential by March 2026 could yield 58.26% accumulated dividend at current $7.04 price. Despite CAEL-101 setback, pipeline remains strong with Emrosi (65% payer coverage), CUTX-101 (FDA decision September), Dotinurad (China launch, potential in multiple indications), and Triplex vaccine (multiple ongoing trials). 255% upside to $25 listing price.
Read full article (18 min)